Journal of Pain and Symptom Management
Volume 25, Issue 1 , Pages 4-5 , January 2003

Intermittent Nasogastric Drainage Under Sedation for Unresponsive Vomiting in Terminal Bowel Obstruction

References 

  1. Ripamonti C, Twycross R, Baines M, et al.  Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer. 2001;9:223–233
  2. Baines MJ. The pathophysiology and management of malignant intestinal obstruction. In:  Doyle D,  Hanks GWC,  MacDonald N editor. Oxford textbook of palliative medicine. Oxford: Oxford University Press; 1998;p. 526–534
  3. Ripamonti C, Mercadante S, Groff L, et al.  Role of octreotide, scopolamine butylbromide and hydration in symptom control of patients with inoperable bowel obstruction having a nasogastric tube. A prospective randomized clinical trial. J Pain Symptom Manage. 2000;19:23–34
  4. Mercadante S, Ripamonti C, Casuccio A, et al.  Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer. 2000;8:188–191
  5. Bentley A, Boyd K. Use of clinical pictures in the management of nausea and vomiting (a prospective audit). Palliat Med. 2001;15:247–253
  6. Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam (a review of its pharmacological properties and therapeutic use). Drugs. 1984;28:519–543

PII: S0885-3924(02)00600-0

Journal of Pain and Symptom Management
Volume 25, Issue 1 , Pages 4-5 , January 2003

Article Tools